Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1Interstate Cannabis

ORTH Insider Trading (Ortho Regenerative Technologies)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $600.00
Insider Selling (Last 12 Months): $89,600.00

Ortho Regenerative Technologies Insider Trading History Chart

Ortho Regenerative Technologies Share Price & Price History

$0.00
+0.30 (1.20%)
As of 07/3/2020 01:00 AM ET
Days: 30 | 90 | 365
Facebook Billionaire Investing in a Shocking New Industry
Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.
And today, you could get in on the ground floor

Ortho Regenerative Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/29/2020Manitex Capital Inc. InsiderSell160,000$0.56$89,600.005,018,858
10/19/2020Luc MainvilleSenior OfficerBuy1,000$0.60$600.00906,000
4/21/2020Luc MainvilleSenior OfficerBuy244,000$0.50$122,000.00708,000
9/27/2019Guy Paul AllardSenior OfficerBuy1,250$0.29$362.5027,350
9/24/2019Guy Paul AllardSenior OfficerBuy1,500$0.26$390.0026,100
9/16/2019Guy Paul AllardSenior OfficerBuy1,000$0.29$290.0024,600
9/13/2019Guy Paul AllardSenior OfficerBuy3,000$0.31$930.0023,600
2/15/2019Luc MainvilleSenior OfficerBuy10,000$0.41$4,080.00561,500
12/6/2018Luc MainvilleInsiderBuy1,000$0.28$280.00
10/10/2018Michael Daro BuschmannInsiderSell10,000$0.36$3,600.00
8/1/2018Michael Daro BuschmannInsiderSell5,000$0.44$2,200.00
See Full Table
Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.
Read More on Ortho Regenerative Technologies

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,500 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Ortho Regenerative Technologies?

Ortho Regenerative Technologies' top insider investors include:
  1. Manitex Capital Inc (Insider)
  2. Luc Mainville (Senior Officer)
  3. Guy Paul Allard (Senior Officer)
Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1Interstate Cannabis